Q2 2026 saw 5% net sales growth and 8% higher net income, with gross margin expanding to 36.9%. Adjusted EBITDA rose 5% to $237.2 million, and share repurchases and acquisitions continued. Full-year guidance anticipates flat to slightly higher organic sales and margin expansion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.